In a phase III trial, a new combination treatment with individualized cancer growth blocking drugs for leukaemia in adults was studied. More than 95 percent of the patients were in remission three years after the start of the treatment, considerably more than with standard treatment.
related: #leukaemia #growth_blocker #combination
Contact: info(@)neat-news(dot)com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
Note that photos are usually stock photos, mostly taken from
Wikipedia, which we can use royalty-free either since they are in
the public domain or available under an open licence such as
a share alike licence.
The page is maintained in Germany and for any legal matters the
laws of Germany apply.
Any warranty or liability is excluded in the widest legally
possible sense.
© neat-news.com 2016-2025.
